OneAscent Wealth Management’s AbbVie ABBV Stock Holding History

OneAscent Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$523K	Buy	2,078 +111	+6%	+$23.9K	0.16%	72
2026 Q1	$428K	Sell	1,967 -61	-3%	-$13.5K	0.14%	79
2025 Q4	$463K	Sell	2,028 -317	-14%	-$72.2K	0.15%	68
2025 Q3	$543K	Sell	2,345 -89	-4%	-$18.1K	0.18%	65
2025 Q2	$452K	Buy	2,434 +612	+34%	+$114K	0.17%	71
2025 Q1	$382K	Sell	1,822 -433	-19%	-$84.2K	0.17%	70
2024 Q4	$401K	Buy	2,255 +132	+6%	+$24.3K	0.17%	75
2024 Q3	$419K	Sell	2,123 -25	-1%	-$4.67K	0.16%	85
2024 Q2	$368K	Sell	2,148 -33	-2%	-$5.47K	0.19%	48
2024 Q1	$397K	Sell	2,181 -367	-14%	-$63.3K	0.15%	95
2023 Q4	$395K	Buy	+2,548	New	+$371K	0.16%	82

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OneAscent Wealth Management's ABBV Position: Q2 2026 in Review

OneAscent Wealth Management increased its AbbVie (ABBV) stake by 5.6% in Q2 2026, buying an estimated $23.9K and bringing the position to 2,078 shares worth $523K. The position accounts for 0.16% of the portfolio, ranked #72.

OneAscent Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $543K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

OneAscent Wealth Management held 2,078 shares of AbbVie worth $523K as of Q2 2026.
OneAscent Wealth Management bought 111 AbbVie shares in Q2 2026, an estimated $23.9K.
AbbVie made up 0.16% of OneAscent Wealth Management's portfolio in Q2 2026, its #72 holding.
OneAscent Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
OneAscent Wealth Management's AbbVie position peaked at $543K in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OneAscent Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.